SEARCH

SEARCH BY CITATION

References

  • 1
    Sobhonslidsuk A, Reddy KR. Portal vein thrombosis: a concise review. Am J Gastroenterol 2002; 97: 535541.
    Direct Link:
  • 2
    Valla D, Casadevall N, Huisse MG, Tulliez M, Grange JD, Muller O, et al. Etiology of portal vein thrombosis in adults: a prospective evaluation of primary myeloproliferative disorders. Gastroenterology 1988; 94: 10631069.
  • 3
    Valla DC, Condat B. Portal vein thrombosis in adults: pathophysiology, pathogenesis and management. J Hepatol 2000; 32: 865871.
  • 4
    Denninger MH, Chait Y, Casadevall N, Hillaire S, Guillin MC, Bezeaud A, et al. Cause of portal or hepatic venous thrombosis in adults: the role of multiple concurrent factors. HEPATOLOGY 2000; 31: 587591.
  • 5
    Martinelli I. Risk factors in venous thromboembolism. Thromb Haemost 2001; 86: 395403.
  • 6
    Mahmoud AEA, Elias E, Beauchamp N, Wilde JT. Prevalence of the factor V Leiden mutation in hepatic and portal vein thrombosis. Gut 1997; 40: 798800.
  • 7
    Chamouard P, Pencreach E, Maloisel F, Grunebaum L, Ardizzone JF, Meyer A, et al. Frequent factor II G20210A mutation in idiopathic portal vein thrombosis. Gastroenterology 1999; 116: 144148.
  • 8
    Janssen HLA, Meinardi JR, Vleggaar FP, van Uum SHM, Haagsma EB, van der Meer FJM, et al. Factor V Leiden mutation, prothrombin gene mutation, and deficiencies in coagulation inhibitors associated with Budd-Chiari syndrome and portal vein thrombosis: results of a case-control study. Blood 2000; 96: 23642367.
  • 9
    Madonna P, De Stefano V, Coppola A, Cerbone AM, Di Minno G. G20210A prothrombin gene mutation and other thrombophilic polymorphisms in patients with portal or hepatic venous thrombosis. Gastroenterology 2001; 120: 10591067.
  • 10
    Mohanty A, Shetty S, Ghosh K, Pawar A, Abraham P. Hereditary thrombophilia as a cause of Budd-Chiari Syndrome: a study from western India. HEPATOLOGY 2001; 34: 666670.
  • 11
    Silingardi M, Ghirarduzzi A, Galimberti D, Iorio A, Iori I. Mesenteric-portal vein thrombosis in a patient with hyperhomocysteinemia and heterozygous for 20210A prothrombin allele. Thromb Haemost 2000; 84: 358359.
  • 12
    Frezzato M, Tosetto A, Rodeghiero F. Validated questionnaire for the identification of previous personal or familial venous thromboembolism. Am J Epidemiol 1996; 143: 12571265.
  • 13
    Bertina RM, Koeleman BPC, Koster T, Rosendaal FR, Dirven RJ, De Ronde H, et al. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 1994; 369: 6467.
  • 14
    Poort SR, Rosendaal FR, Reitsma PH, Bertina RM. A common genetic variation in the 3′-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood 1996; 88: 36983703.
  • 15
    Martinelli I, Sacchi E, Landi G, Taioli E, Duca F, Mannucci PM. High risk of cerebral-vein thrombosis in carriers of a prothrombin-gene mutation and in users of oral contraceptives. N Engl J Med 1998; 338: 17931797.
  • 16
    Brandt JT, Triplett DA, Alving B, Scharrer I. Criteria for the diagnosis of lupus anticoagulants: an update. Thromb Haemost 1995; 74: 11851190.
  • 17
    Zighetti ML, Cattaneo M, Falcon CR, Lombardi R, Harari S, Savoritto S, et al. Absence of hyperhomocysteinemia in ten patients with primary pulmonary hypertension. Thromb Res 1997; 85: 279282.
  • 18
    Martinelli I, Bucciarelli P, Zighetti ML, Cafro A, Mannucci PM. Low risk of thrombosis in family members of patients with hyperhomocysteinemia. Br J Haematol 2002; 117: 709711.
  • 19
    Cattaneo M, Martinelli I, Mannucci PM. Hyperhomocysteinemia as a risk factor for deep-vein thrombosis. N Engl J Med 1996; 335: 974975.
  • 20
    Rosenberg RD, Aird WC. Vascular-bed-specific hemostasis and hypercoagulable states. N Engl J Med 1999; 340: 15551564.
  • 21
    Martinelli I, Battaglioli T, Bucciarelli P, Passamonti SM, Mannucci PM. Risk factors and recurrence rate of primary deep vein thrombosis of the upper extremities. Circulation 2004; 110: 566570.
  • 22
    Psaty BM, Smith NL, Lemaitre RN, Vos HL, Keckbert SR, LaCroix AZ, et al. Hormone replacement therapy, prothrombotic mutation, and the risk of incident nonfatal myocardial infarction in postmenopausal women. JAMA 2000; 285: 906913.
  • 23
    Reny JL, Alhenc-Gelas M, Fontana P, Bissery A, Julia PL, Fiessinger JN, et al. The factor II G20210A gene polymorphism, but not factor V Arg506Gln, is associated with peripheral arterial disease: results of a case control study. J Thromb Haemost 2004; 2: 13341340.
  • 24
    Bosy-Westphal A, Ruschmeyer M, Czech N, Oehler G, Hinrichsen H, Plauth M, et al. Determinants of hyperhomocysteinemia in patients with chronic liver disease and after orthotopic liver transplantation. J Clin Nutr 2003; 77: 12691277.